SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as the community debates whether the stock is a deep-value turnaround play or a failing brand, with discussions centering on massive insider buying from top leadership, planned layoffs, and potential tariff refunds. While many retail investors are cautious due to persistent selling pressure and negative sentiment regarding recent product strategy, others are accumulating at current lows, betting that the company will recover through restructuring and high-profile upcoming sports events.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as the community debates a sharp disconnect between record-setting earnings and the stock's muted price reaction, with many investors dismissing the stagnation as market manipulation or a temporary shakeout of weak hands. While bears highlight valuation concerns and a high P/E ratio, a vocal group of bulls remains highly confident, viewing the latest growth metrics and raised guidance as evidence that the companys AI-driven momentum will inevitably drive the stock to new highs.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing high volatility as investors react to legislative updates regarding the Clarity Act and its potential impact on stablecoin yields. The community remains deeply divided, with some traders focused on bullish technical breakouts and long-term infrastructure utility, while others are wary of regulatory hurdles, ongoing class-action litigation, and recent analyst downgrades.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is experiencing extreme volatility following a significant drone asset acquisition agreement, sparking intense community debate between traders chasing the low-float momentum and skeptics warning of dilution risks. Investors are closely monitoring the stock's rapid price swings and frequent halts as participants argue over the company's valuation versus its potential as a short-term squeeze candidate.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to a new commercialization partnership and recent analyst coverage that highlights significant potential in the firm's localized prostate cancer program. The community is actively debating the stock's valuation, upcoming data readouts, and the strategic positioning of management as the company works toward a BLA filing.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is facing intense market skepticism following a shift toward prioritizing user engagement over short-term monetization, leading to concerns about slowing revenue growth and potential AI disruption. While the community is sharply divided between those calling it a "dying" company due to competitive pressure and those viewing it as a long-term, undervalued growth play with strong fundamentals, active discussions remain dominated by volatility concerns and skepticism over its future moat.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following the announcement of its $643 million acquisition of Eigen AI, a strategic move aimed at optimizing inference performance for its Token Factory platform. While investors are debating the company's valuation and long-term capital strategy, the community remains heavily focused on its infrastructure build-out and aggressive growth guidance ahead of upcoming earnings.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies (XNDU) is experiencing extreme volatility following an SEC filing that registered nearly 300 million shares for resale, triggering widespread confusion among retail investors about potential dilution. While some community members fear a massive sell-off from early insiders, others argue the price action is an overreaction to an unlock of existing shares and are actively debating whether to buy the dip for a potential short squeeze.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is seeing significant market activity driven by an oversubscribed private placement financing, which investors are weighing against concerns over historical share dilution. The community is actively debating whether the move signals a genuine valuation shift or a typical volatile setup, with traders closely monitoring key support levels for signs of a parabolic continuation.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx Holdings is seeing significant volatility as investors digest a guidance reset and conflicting institutional signals, with the community actively debating whether the recent sell-off represents a buying opportunity or a deeper trend of fundamental weakness. The stock remains a major talking point as market participants analyze heavy insider buying against concerns about the company's long-term growth sustainability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is State Street SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?

Should You Invest in the State Street SPDR S&P Insurance ETF (KIE)?

<ul class="summary-bullets"><li>CEO Stephen Hemsley released a prepared testimony ahead of his appearance before the Energy and Commerce Subcommittee on Health later this week.</li><li>Hemsley called on lawmakers to pursue broader reforms to health savings accounts, care delivery rules, patent laws, and drug pricing to improve healthcare affordability.</li><li>UnitedHealth negotiated nearly $300 billion in discounts in 2025, Hemsley said.</li></ul>UnitedHealth Group Inc. (UNH) plans to refund profits from its Affordable Care Act (ACA) plans, famously known as Obamacare, to customers in 2026, a move that comes as Congress debates whether to extend enhanced tax credits that support those plans.The announcement was made by chief executive officer Stephen Hemsley in a prepared testimony released ahead of his appearance before the United States House of Representatives Committee on Energy &amp; Commerce, Subcommittee on Health, later this week.Earlier this month, the U.S. House of Representatives voted to extend ACA subsidies for another three years. The measure passed 230–196, with support from 213 Democrats and 17 Republicans, renewing Obamacare tax credits that had expired at the end of 2025. The bill now heads to the Senate for further consideration.Insurers have faced mounting pressure from President Donald Trump, who has opposed extending the additional ACA subsidies.“Though UnitedHealthcare is a relatively small participant in the individual ACA market, we will voluntarily eliminate and rebate our profits this year for these coverages,” Hemsley’s statement read.<h2 class="st-heading-2">Thin Margins</h2>UnitedHealth executives have previously described ACA margins as thin. Chief Financial Officer Wayne DeVeydt said in November that the business was expected to generate “low single-digit” margins. The company also raised ACA premiums by an average of 25% for 2026.Hemsley urged lawmakers to consider broader reforms, including changes to health savings accounts, site-of-care rules, patent laws, and drug pricing, to help make healthcare more affordable and sustainable over time.In the prepared testimony, Hemsley emphasized broader cost pressures across the U.S. healthcare system, noting that healthcare spending per person has surged over the past 25 years, driven by rising hospital prices, prescription drug costs, and specialty care. He highlighted UnitedHealth’s efforts to mitigate those pressures, including negotiating nearly $300 billion in discounts last year.At the time of writing, <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> was up 2.4% while shares of insurers with heavier exposure to ACA coverage dropped sharply, with <a href="https://stocktwits.com/symbol/CNC">Centene Corp shares</a> sliding 2.4% and <a href="https://stocktwits.com/symbol/OSCR">Oscar Health stock</a> falling 7%.<h2 class="st-heading-2">Potentially Masterful Move</h2>Baird sees UnitedHealth's plan to rebate its ACA profit to customers as a “potentially masterful move”.&nbsp; If the company’s announcement leads the government to implement health exchange profit rebate measures, “this could be a masterful chess move in placing potential pressure on competitor HIX plans who heavily rely on these profits in 2026,” the brokerage added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for UNH changed to ‘neutral’ from ‘extremely bearish’ a day earlier. One Stocktwits user highlighted the company’s strength.<stembedurl>https://stocktwits.com/dan4100/message/642413792</stembedurl>Another user sees a move beyond the $350 and $367 levels, leading to a rally toward $400. The stock is currently trading at $345.8.<stembedurl>https://stocktwits.com/SlickBrag/message/642424684</stembedurl>Over the past year, UNH shares have declined by around 33%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-pavm-stock-surge-today/cmUDHKRR4fS">PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the UnitedHealth Group logo is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

UnitedHealth Pledges ACA Profit Rebates Amid Subsidy Debate – But Retail Sees Rally Toward $400 

UnitedHealth Group Inc. plans to rebate profits from its Affordable Care Act plans, also known as Obamacare, to customers in 2026.

Equity

<ul class="summary-bullets"><li>Ever since late October, UNH stock has been in a corrective mode, sliding from its high of $381 following its third-quarter earnings.</li><li>UNH has stayed below its 200-day moving average since mid-April.</li><li>Insurance stocks gained on Thursday after the U.S. Senate rejected both Republican and Democratic proposals to address expiring healthcare subsidies.</li></ul>UnitedHealth Group Inc. (UNH) shares have drawn heavy interest from retail investors on Friday morning as it appears set to clear a key hurdle at $340 following the U.S. Senate’s rejection of Republican and Democratic proposals to address expiring healthcare subsidies.The $340 mark coincides with the stock’s 50-day moving average (50-DMA), currently at around $340.71 – a key hurdle which, if crossed, will be considered as a positive signal for the short term. Ever since late October, UNH stock has been in a corrective mode, sliding from its high of $381 following its third-quarter earnings.&nbsp;<figure class="image"><img style="aspect-ratio:1315/927;" src="https://news.stocktwits-cdn.com/UNH_png_a079cadf0a.webp" alt="UNH.png" width="1315" height="927"><figcaption>UNH-50 DMA on Dec. 11, 2025 | Source: Stocktwits</figcaption></figure>Though revenue rose 12% to $113.2 billion in the quarter, higher medical costs and Medicare funding cuts pressured profits. Net income dropped to $2.54 billion from $6.56 billion, and net margins slid sharply to 2.1% from 6%. The stock has stayed below its 200-day moving average since mid-April.<h2 class="st-heading-2">The Healthcare Plan Deadlock</h2>On Thursday, insurance stocks rose after the U.S. Senate rejected proposals to address expiring healthcare subsidies. Although ACA premiums are expected to increase and tax credits are ending this year, investors had largely priced in the impact. They reportedly viewed the Republican plan as the bigger risk.That plan would eliminate the enhanced tax credits and instead put the funds into Health Savings Accounts for those buying bronze or “catastrophic” ACA plans, providing $1,000 for individuals aged 18 to 49, and $1,500 for those aged 50 to 64.<h2 class="st-heading-2">UnitedHealth’s Financial Plans</h2>Last month, UnitedHealth launched a three-year turnaround plan aimed at restoring profitability and what the new CFO, Wayne DeVite, described as the company’s “swagger” by 2027. The strategy includes dropping unprofitable Medicare Advantage and ACA plans, and sharpening its focus on U.S. operations.UnitedHealth also priced its 2026 plans with a higher 10% medical-cost trend to address inflation pressures. As part of the overhaul, the company plans to sell non-core international assets, reduce debt, and resume share buybacks in late 2026. It has already agreed to sell its final South American asset, Banmedica, to Patria Investments for about $1 billion.Despite raising its 2025 profit outlook and signaling strong momentum into 2026 and 2027, the company still faces elevated medical costs, especially in its Medicaid business.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits shifted to ‘bearish’ from ‘extremely bearish’ a day earlier. <a href="https://stocktwits.com/symbol/UNH">UNH</a> was also among the top trending tickers on the platform.One user sees $340 as a crucial level. The stock is currently near $338.<stembedurl>https://stocktwits.com/RockyTSTH/message/638961001</stembedurl>Year-to-date, the stock has declined more than 33%.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/robert-reich-warns-trump-grip-on-private-sector-paramount-netflix-battle-wbd/cLIChD0REFi">Robert Reich Sounds Alarm: Trump’s Grip On Private Sector In Spotlight As Paramount, Netflix Battle For WBD Heats Up</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

UNH Shares Appear Set For Potential Breakout Above $340 –  Why It’s Crucial For The Stock To Clear This Key Hurdle?

The $340 mark coincides with the stock’s 50-day moving average (50-DMA), currently at around $340.71 – a key hurdle which, if crossed, will be considered as a positive signal for the short term.

Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?

FTSE 100 today: Index, pound drop; Centrica gains on Sizewell C stake;Compass rise

Kier CEO Davies to retire in October, shares fall; FY25 results to be in line

Investing.com --  Kier Group  (LON:KIE) reported strong full-year trading, with revenue and profit expected to be in line with board expectations.

Current Price	$56.26
Prev Close	$56.79
Open	$56.54
Dividend Yield	N/A
50-Day Moving Average	$56.50
Beta	N/A
Avg. Volume	1.09M
PE Ratio	N/A

52-Week High	$61.26
52-Week Low	$53.45
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

KIE
SPDR S&P Insurance ETF

Feed

News

Sentiment

Fundamentals

Info

Latest KIE News

KIESPDR S&P Insurance ETF